PPT-RF CATHETER Ablation as First line treatment for Atrial FIBRILLATION

Con Amr Kamal MD Alexandria Main University Hospital Alexandria Egypt ECRA 2010 General Rules In order to consider AF ablation as a first line therapy we should have clear and evidence based answers for the following 5 questions. John M Mandrola, MD, Vicky A Swift, APRN, Kathryn Grace Thorne, MS, Sean . Kettring. , David E Mann, MD. Baptist Hospital East, Louisville, KY. .. No Author has any disclosures.  . Abstract. Introduction. Buttu. A.. 1. , Van . Zaen. J.. 1. , . Viso. A.. 1. , . Forclaz. A.. 2. , Pascale P.. 2. , Narayan S.. 3. , . Vesin. J.. 1. , . Pruvot. E.. 2. 1. Applied Signal Processing Group, Swiss Federal Institute of Technology EPFL, Lausanne – Switzerland. Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . & Minimally Invasive Cox Maze Procedure If you have atrial fibrillation, also called AF, your doctor may discuss several treatment options with you. These options may include surgery. Advanced sur Carlos Calle-Muller, MD. Cardiac Electrophysiology. 734-855-9448. Objectives. To recognize the risks for patients with atrial fibrillation. To familiarize with the management of atrial fibrillation. Atrial fibrillation (AF) is the most common cardiac arrhythmia . Analyses Using CMS data. Susan R. Heckbert, MD, PhD. University of Washington. Analyses using CMS data. Methods. Strengths & limitations. Application in MESA. Applications outside . MESA. Medicare 5% sample, 100% sample. Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH. David MacLennan. NHS Lothian/Fife. South East Scotland Deanery. Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH e-mail: david.maclennan@nhslothian.scot.nhs.uk. abstract. Nassir F. Marrouche, MD. , Oussama . Wazni. , MD, Tom Greene, PhD, J Michael Dean, MD, Eugene . Kholmovski. , PhD, Moussa Mansour, MD, Hugh Calkins, MD, Francis . Marchlinski. , MD, David Wilber, MD, Gerhard . Freedom . from atrial fibrillation at 12 . months: 63. % of the mitral valve surgery plus ablation group . vs. . 29% of the mitral valve surgery alone group (p < . 0.001). Among . the ablation group, freedom from atrial fibrillation occurred in 61% with PVI vs. 66% with . HEARTSERIESH9 Theinformationcontainedinthisbookletisbasedonguidelinesandpracticeand iscorrectattimeofprinting.Thecontenthasundergonepee,patientandexpertrevie. Theinformationcontainedinthisbookletisba